You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Attention Score in Context
High efficacy and safety of CD38 and BCMA bispecific CAR-T in relapsed or refractory multiple myeloma
Journal of Experimental & Clinical Cancer Research, January 2022
Yuanyan Tang, Haisen Yin, Xinying Zhao, Dan Jin, Yan Liang, Tao Xiong, Lu Li, Wen Tang, Jiangzhao Zhang, Min Liu, Zhuojun Yu, Huimin Liu, Sibin Zang, Zhiping Huang
The data shown below were collected from the profiles of 5 tweeters who shared this research output. Click here to find out more about how the information was compiled.
|Members of the public||4||80%|
|Science communicators (journalists, bloggers, editors)||1||20%|
The data shown below were compiled from readership statistics for 36 Mendeley readers of this research output. Click here to see the associated Mendeley record.
|Readers by professional status||Count||As %|
|Student > Master||5||14%|
|Student > Ph. D. Student||5||14%|
|Readers by discipline||Count||As %|
|Medicine and Dentistry||8||22%|
|Biochemistry, Genetics and Molecular Biology||6||17%|
|Immunology and Microbiology||3||8%|
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 January 2022.
All research outputs
of 23,314,015 outputs
Outputs from Journal of Experimental & Clinical Cancer Research
of 2,098 outputs
Outputs of similar age
of 508,167 outputs
Outputs of similar age from Journal of Experimental & Clinical Cancer Research
of 80 outputs
Altmetric has tracked 23,314,015 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,098 research outputs from this source. They receive a mean Attention Score of 4.0. This one has gotten more attention than average, scoring higher than 72% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 508,167 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.
We're also able to compare this research output to 80 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 75% of its contemporaries.